“Financial Relationships with Industry in Continuing Medical Education,” the much anticipated follow-up report from the American Medical Association’s Council on Ethical and Judicial Affairs, has not yet reached the end of what is turning out to be a long and winding road to acceptance. At the AMA’s House of Delegates (HOD) meeting in Chicago in June, the association sent it back for more study instead of adopting it as it stood. As is often the case with issues involving pharmaceutical ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only unlock thePrinter-friendly, you'll also gain access to exclusive premium content.

Already registered? here.